Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Remifentanil for Analgesia in Mechanically Ventilated ICU Patients
NCT06454292Phase 4Not yet recruiting
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, single-blind trial of oliceridine in pain (2 arms). Primary endpoint: Assessment of analgesic effectiveness at 3 days. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06454292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06454292.